Found 10 matching trials
Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
PHASE1The purpose of this study is to find the highest safe dose and to assess th...
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
PHASE1This is a Phase 1, randomized, open-label, 2-way crossover, pharmacokinetic...
Location
Multiple Locations
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
PHASE2The goal of this clinical research study is to learn if treatment with the ...
Location
UT MD Anderson Cancer Center
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
PHASE2Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Location
University of Texas MD Anderson Cancer Center
Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction
PHASE1The purpose of this study is to see how vincristine, when placed in an oil ...
Location
University of Texas M.D. Anderson Cancer Center
Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL
PHASE1This was a Phase 1/2 study performed at two clinical centers in the US and ...
Location
University of California
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
PHASE2This was a Phase 2, international, multicenter, open-label, single-arm tria...
Location
USC - Norris Cancer Center
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
PHASE2This is a phase-II study to evaluate the efficacy of a salvage regimen in c...
Location
St. Jude Children's Research Hospital
Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
PHASE1The main purpose of this investigational research study is to determine how...
Location
Stanford University
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
PHASE3A phase 3 study in the treatment of subjects \>or= 60 years old with newly ...
Location
UC San Diego Moores Cancer Center